Literature DB >> 34546390

Comparison of single versus double tranexamic acid dose regimens in reducing post-operative blood loss following intramedullary nailing of femoral fracture nonunions.

Olaoluwa Moses Shodipo1, Hamzah Ibrahim Jatto2, Ali Mohammed Ramat3, Shaphat Shuaibu Ibrahim4, Lukman Olalekan Ajiboye5, Soluideen Adebayo Arojuraye6, John Adeniran James7, Adetunji Mapaderun Toluse8.   

Abstract

INTRODUCTION AND
AIM OF STUDY: Tranexamic acid has been found to be effective in reducing peri-operative blood loss and is widely used across surgical specialties including orthopaedic surgery. However, there is still no consensus on the most appropriate and effective dose regimen. This study therefore compared the efficacy of single versus double dose regimens in patients that had interlocking intramedullary nailing by assessing the volume of drain output with the objective of determining the more effective regimen.
METHODS: The study was a multicenter prospective study amongst adult patients who had interlocking intramedullary nailing for femoral nonunions. Following ethical approval, consent was obtained from eligible patients who were randomly assigned into two study groups. Group A patients had single pre-incision tranexamic acid bolus of one gram while group B patients had a second (repeat) one gram bolus (at the completion of wound closure). The volume of drain output at 48 h postop was the primary outcome measure and data collection was via an online data collection form linked to the google drive of the principal investigator. The mean of the drain output of the two groups was compared for statistical significance.
RESULTS: A total of 61 patients participated in the study with 30 patients in group A and 31 patients in group B. The demographic data and duration of fracture were comparable in the two groups. Group A had a mean drain volume of 274.80 ml (± 103.93 ml) while group B had a mean of 187.94 ml (± 41.95 ml) and the difference was found to be statistically significant. (P, 0.000).
CONCLUSION: The findings suggest that double dose perioperative tranexamic acid regimen is superior to single-dose peri-operative tranexamic acid regimen in reducing post-operative blood loss in patients undergoing interlocking intramedullary nailing for femoral nonunions.
© 2021. The Author(s) under exclusive licence to SICOT aisbl.

Entities:  

Keywords:  Femoral fracture nonunions; Intramedullary nailing; Post-operative blood loss; Tranexamic acid

Mesh:

Substances:

Year:  2021        PMID: 34546390     DOI: 10.1007/s00264-021-05220-0

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  12 in total

1.  Complications of fracture treatment by traditional bonesetters in southwest Nigeria.

Authors:  D A OlaOlorun; I O Oladiran; A Adeniran
Journal:  Fam Pract       Date:  2001-12       Impact factor: 2.267

Review 2.  Review of the practice of traditional bone setting in Nigeria.

Authors:  A A Dada; W Yinusa; S O Giwa
Journal:  Afr Health Sci       Date:  2011-06       Impact factor: 0.927

3.  The use of tranexamic acid to reduce blood loss and transfusion in major orthopedic surgery: a meta-analysis.

Authors:  Fei Huang; Dan Wu; Guangwen Ma; Zongsheng Yin; Qing Wang
Journal:  J Surg Res       Date:  2013-09-13       Impact factor: 2.192

4.  Tranexamic Acid Reduces Postoperative Blood Loss in Distal Femoral Osteotomy.

Authors:  Michael E Steinhaus; Joshua Buksbaum; Avraham Eisenman; Monal Kohli; Austin T Fragomen; S Robert Rozbruch
Journal:  J Knee Surg       Date:  2019-02-12       Impact factor: 2.757

5.  Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.

Authors:  Rajesh N Maniar; Gaurav Kumar; Tushar Singhi; Ravi Mohan Nayak; Parul R Maniar
Journal:  Clin Orthop Relat Res       Date:  2012-03-15       Impact factor: 4.176

6.  Reduction of blood loss with tranexamic acid in primary total hip replacement surgery.

Authors:  M A Claeys; N Vermeersch; P Haentjens
Journal:  Acta Chir Belg       Date:  2007 Jul-Aug       Impact factor: 1.090

Review 7.  Tranexamic Acid in Hip and Knee Arthroplasty.

Authors:  J Stuart Melvin; Louis S Stryker; Rafael J Sierra
Journal:  J Am Acad Orthop Surg       Date:  2015-10-22       Impact factor: 3.020

8.  Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety.

Authors:  Jashvant Poeran; Rehana Rasul; Suzuko Suzuki; Thomas Danninger; Madhu Mazumdar; Mathias Opperer; Friedrich Boettner; Stavros G Memtsoudis
Journal:  BMJ       Date:  2014-08-12

9.  The effect of different dose regimens of tranexamic acid in reducing blood loss during hip surgery.

Authors:  Anil Kumar Thipparampall; Indira Gurajala; R Gopinath
Journal:  Indian J Anaesth       Date:  2017-03

10.  Low Dose Perioperative Intravenous Tranexamic Acid in Patients Undergoing Total Knee Arthroplasty: A Double-Blind Randomized Placebo Controlled Clinical Trial.

Authors:  Mahdi Motififard; Mohammad Ali Tahririan; Mehdi Saneie; Sajad Badiei; Amin Nemati
Journal:  J Blood Transfus       Date:  2015-12-06
View more
  3 in total

1.  Comment on article by Shodipo et al.: comparison of single versus double tranexamic acid dose regimens in reducing post-operative blood loss following intramedullary nailing of femoral fracture nonunions.

Authors:  Jue-Fu Cheng; Wen-Qiang Qian; Mumingjiang Yishake; Jin-Wen Shen
Journal:  Int Orthop       Date:  2021-10-21       Impact factor: 3.075

2.  Comment on Shodipo et al.: comparison of single versus double tranexamic acid dose regimens in reducing post-operative blood loss following intramedullary nailing of femoral fracture nonunions.

Authors:  Zhicheng Pan; Ting Xu
Journal:  Int Orthop       Date:  2021-10-23       Impact factor: 3.075

3.  Comment on article by Zhong et al.: Local administration of epsilon-aminocaproic acid reduces post-operative blood loss from surgery for closed, Sanders III-IV calcaneal fractures.

Authors:  Xiao-Long Fan
Journal:  Int Orthop       Date:  2022-03-09       Impact factor: 3.479

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.